OneChain Immunotherapeutics
Estibaliz Glaría Percaz, Ph.D., currently serves as a Senior Research Scientist at OneChain Immunotherapeutics since March 2022, after a brief tenure as a Research Scientist at GAT Therapeutics from September 2021 to March 2022, where focus lay on preclinical research in fibrosis and age-related diseases. Prior academic experience includes a significant role as a Doctoral Researcher in Biomedicine and Immunology at Universitat de Barcelona from September 2015 to October 2021, investigating the modulation of inflammatory activities by Liver X Receptors and teaching laboratory practicals in Immunology. Additional research experience spans various positions including a Research Fellow at the University Medical Center Hamburg-Eppendorf and multiple research internships in immunology and molecular biology across different institutions. Estibaliz holds a Master’s degree in Advanced Immunology and a Bachelor’s degree in Biomedical Sciences, both from Universitat de Barcelona.
This person is not in any teams
OneChain Immunotherapeutics
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.